A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
about
Pharmacological treatments for fatigue associated with palliative careDrug therapy for the management of cancer-related fatigueDrug therapy for the management of cancer related fatigueMedroxyprogesterone acetate enhances in vivo and in vitro antibody productionClinical anticachexia treatments.Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications.Medroxyprogesterone acetate in the management of cancer cachexia.Placebo effects in oncology.Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect.Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.Modafinil for the treatment of fatigue in lung cancer: a pilot study.Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: report of a case and the role of team medical care.
P2860
Q24187756-15030A30-7EE7-4AF4-9363-11BA29313D6FQ24234267-D058B4BE-6FFA-4AFC-8016-0CCD1722A602Q24242050-65B1842B-27F5-4D2D-BFBD-92160D16BA82Q28360458-ADA07952-26A4-4D39-8391-171E41B4AA48Q33994400-54EBA4A4-00FF-4F38-AB98-CF08540B35F4Q34058941-66CDB341-E02F-4C96-8F85-F9BE8C04CBCFQ34607739-0A3C7DC3-40B3-44C1-98F4-D0E479F4645BQ35037527-A195BFC5-E343-445B-A47C-251323654A0EQ36618202-B579B415-9DD6-49C2-8CB6-CDA592F6A2A1Q38290238-78441D3E-95EF-4CF4-ABA4-CEC07999BA6DQ46095786-ACE6B669-E858-4A3E-95EC-099FAC76A7D8Q51991171-CC3C7D7C-1B31-4121-A70B-CA305FC77CD3
P2860
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@ast
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@en
type
label
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@ast
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@en
prefLabel
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@ast
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@en
P2093
P2860
P356
P1476
A double blind placebo control ...... tate (MPA) in cancer cachexia.
@en
P2093
Allbright A
P2860
P2888
P304
P356
10.1038/BJC.1993.202
P407
P577
1993-05-01T00:00:00Z
P5875
P6179
1036342266